UMP Healthcare Holdings Management
Management criteria checks 3/4
UMP Healthcare Holdings' CEO is Jacquen Kwok, appointed in Jan 2023, has a tenure of 10.17 years. total yearly compensation is HK$5.49M, comprised of 94.7% salary and 5.3% bonuses, including company stock and options. directly owns 2.4% of the company’s shares, worth HK$8.16M. The average tenure of the management team and the board of directors is 2 years and 9.4 years respectively.
Key information
Jacquen Kwok
Chief executive officer
HK$5.5m
Total compensation
| CEO salary percentage | 94.7% |
| CEO tenure | 2yrs |
| CEO ownership | 2.4% |
| Management average tenure | 2yrs |
| Board average tenure | 9.4yrs |
Recent management updates
Recent updates
UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.02
Nov 27
There May Be Some Bright Spots In UMP Healthcare Holdings' (HKG:722) Earnings
Nov 04UMP Healthcare Holdings (HKG:722) Will Pay A Dividend Of HK$0.02
Oct 28UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.02
Sep 29UMP Healthcare Holdings (HKG:722) Is Paying Out Less In Dividends Than Last Year
Mar 02UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03
Dec 01UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03
Oct 26UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03
Sep 24UMP Healthcare Holdings (HKG:722) Will Pay A Larger Dividend Than Last Year At HK$0.017
Feb 26UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.03
Nov 16UMP Healthcare Holdings (HKG:722) Will Pay A Larger Dividend Than Last Year At HK$0.03
Oct 26UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.03
Sep 26Here's What To Make Of UMP Healthcare Holdings' (HKG:722) Decelerating Rates Of Return
May 13UMP Healthcare Holdings (HKG:722) Is Paying Out A Larger Dividend Than Last Year
Feb 27UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.028
Nov 27We Think UMP Healthcare Holdings Limited's (HKG:722) CEO Compensation Package Needs To Be Put Under A Microscope
Nov 19Investors Can Find Comfort In UMP Healthcare Holdings' (HKG:722) Earnings Quality
Oct 29UMP Healthcare Holdings' (HKG:722) Dividend Will Be Increased To HK$0.028
Oct 12UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.028
Sep 25UMP Healthcare Holdings (HKG:722) Might Be Having Difficulty Using Its Capital Effectively
Jul 27A Look At The Fair Value Of UMP Healthcare Holdings Limited (HKG:722)
Apr 29CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | HK$5m | HK$5m | HK$41m |
| Mar 31 2024 | n/a | n/a | HK$37m |
| Dec 31 2023 | n/a | n/a | HK$34m |
| Sep 30 2023 | n/a | n/a | HK$47m |
| Jun 30 2023 | HK$6m | HK$5m | HK$60m |
| Mar 31 2023 | n/a | n/a | HK$64m |
| Dec 31 2022 | n/a | n/a | HK$68m |
| Sep 30 2022 | n/a | n/a | HK$70m |
| Jun 30 2022 | HK$4m | HK$4m | HK$71m |
| Mar 31 2022 | n/a | n/a | HK$72m |
| Dec 31 2021 | n/a | n/a | HK$73m |
| Sep 30 2021 | n/a | n/a | HK$74m |
| Jun 30 2021 | HK$4m | HK$4m | HK$74m |
| Mar 31 2021 | n/a | n/a | HK$66m |
| Dec 31 2020 | n/a | n/a | HK$59m |
| Sep 30 2020 | n/a | n/a | HK$59m |
| Jun 30 2020 | HK$4m | HK$4m | HK$59m |
| Mar 31 2020 | n/a | n/a | HK$67m |
| Dec 31 2019 | n/a | n/a | HK$75m |
| Sep 30 2019 | n/a | n/a | HK$44m |
| Jun 30 2019 | HK$5m | HK$4m | HK$13m |
| Mar 31 2019 | n/a | n/a | HK$8m |
| Dec 31 2018 | n/a | n/a | HK$3m |
| Sep 30 2018 | n/a | n/a | HK$20m |
| Jun 30 2018 | HK$5m | HK$4m | HK$38m |
Compensation vs Market: Jacquen's total compensation ($USD704.64K) is above average for companies of similar size in the Hong Kong market ($USD231.50K).
Compensation vs Earnings: Jacquen's compensation has been consistent with company performance over the past year.
CEO
Jacquen Kwok (56 yo)
2yrs
Tenure
HK$5,490,000
Compensation
Ms. Cheuk Kwan Kwok, also known as Jacquen, served as the Managing Director of UMP Healthcare Holdings Limited until January 01, 2023, serves as its Executive Director since August 29, 2015 and serves as i...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 9.8yrs | HK$5.32m | 31.36% HK$ 106.6m | |
| Co-CEO & Executive Director | 2yrs | HK$5.49m | 2.4% HK$ 8.2m | |
| Co-CEO & Executive Vice Chairman | 9.4yrs | HK$5.78m | 2.59% HK$ 8.8m | |
| Executive Director | 9.4yrs | HK$272.00k | 0.56% HK$ 1.9m | |
| Executive Director | no data | HK$272.00k | 2.87% HK$ 9.8m | |
| Company Secretary | 1yr | no data | no data |
2.0yrs
Average Tenure
54.5yo
Average Age
Experienced Management: 722's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 9.8yrs | HK$5.32m | 31.36% HK$ 106.6m | |
| Co-CEO & Executive Director | 10.2yrs | HK$5.49m | 2.4% HK$ 8.2m | |
| Co-CEO & Executive Vice Chairman | 9.4yrs | HK$5.78m | 2.59% HK$ 8.8m | |
| Executive Director | 9.4yrs | HK$272.00k | 0.56% HK$ 1.9m | |
| Executive Director | 6.9yrs | HK$272.00k | 2.87% HK$ 9.8m | |
| Independent Non-Executive Director | 9.2yrs | HK$290.00k | 0.51% HK$ 1.7m | |
| Independent Non-Executive Director | 1.2yrs | HK$145.00k | no data | |
| Non-Executive Director | 9.4yrs | HK$272.00k | 1.42% HK$ 4.8m | |
| Independent Non-Executive Director | 9.2yrs | HK$240.00k | 0.042% HK$ 141.1k |
9.4yrs
Average Tenure
58yo
Average Age
Experienced Board: 722's board of directors are considered experienced (9.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 03:05 |
| End of Day Share Price | 2025/01/28 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
UMP Healthcare Holdings Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kam Wai Kwok | CGS International |
| Geng Chen | Phillip Securities (HK) |